Effects of Hazelnuts and Cocoa on Metabolic Parameters and Vascular Reactivity
Cardiovascular Diseases, Glucose Metabolism Disorders
About this trial
This is an interventional health services research trial for Cardiovascular Diseases focused on measuring Hazelnut, Cocoa, Flavonoid, Lipids, Vascular Reactivity
Eligibility Criteria
Inclusion Criteria:
- BMI 18.5-24.9 kg/m2
Exclusion Criteria:
- diabetes mellitus
- glucose intolerance
- dyslipidemia
- metabolic syndrome
- allergies
Sites / Locations
- San Donato Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Experimental
Experimental
Experimental
Experimental
Experimental
Placebo Comparator
30g peeled hazelnuts cream
30g unpeeled hazelnuts cream
snack w/ 30g peeled hazelnuts
snack w/ 2.5g cocoa powder
snack w/ 30g peeled hazelnuts+2.5g cocoa
empty snack
Every person in this group will receive a 30 g peeled hazelnuts cream as an integration to his usual breakfast, and will be asked not to change his diet and physical activity during the 2-week trial.
Every person in this group will receive a 30 g unpeeled hazelnuts cream as an integration to his usual breakfast, and will be asked not to change his diet and physical activity during the 2-week trial.
Every person in this group will receive a snack with 30 g peeled hazelnuts as an integration to his usual breakfast, and will be asked not to change his diet and physical activity during the 2-week trial.
Every person in this group will receive a snack with 2.5 g cocoa powder as an integration to his usual breakfast, and will be asked not to change his diet and physical activity during the 2-week trial.
Every person in this group will receive a snack with 30 g peeled hazelnuts and 2.5 g cocoa powder as an integration to his usual breakfast, and will be asked not to change his diet and physical activity during the 2-week trial.
Every person in this group will receive an empty snack as an integration to his usual breakfast, and will be asked not to change his diet and physical activity during the 2-week trial.